Replies to post #33648 on Lifeline Biotechnologies Inc (LLBO)

[GetSeriousOK]

It was called the First Warning System (FWS) in 2008. Why not call it THAT?

It's not a 30% - 35% share ownership in Cyrcadia/Asia-USA -- it's a 30% share ownership in CyrcadiaUSA and a 0% ownership in Cyrcadia-Asia.

And that 30% "ownership" is going to drop when/if the Preferred Stock holders ever convert into common shares.

Acropolis might "care about that" Cyrcadia stock but there's nothing they can do about Cyrcadia, the Cyrcadia Breast Monitor, the clinical trials, or a submission to the FDA.

Cyrcadia is a private company. Acropolis can't petition for custodianship of a private company. And if they rescind Holmes' shares in LLBO as they suggested in one of their tweets, they will make the doddering old fool angry, and they need Holmes to cooperate if they ever expect to get anything for the Cyrcadia stock that LLBO owns.

Acropolis said in another tweet that they will let the reverse-merging company deal with those kinds of issues. Acropolis probably won't do anything about Cyrcadia -- they want to dump these shell tickers, not work on them. And Acropolis has their hands full trying to get the shells Pink Current.

Something apparently went wrong with KAST.... Acropolis clearly was trying to get "Pink Current" and not just "Pink Limited Information" because for "Limited" you only need to file annual statements, and Acropolis filed quarterly statements for KAST. The Attorney's Letter is missing.

* If they filed an Attorney's Letter by the June 30 deadline, it certainly looks like OTCmarkets didn't like the Attorney's letter.

* If they didn't file the Attorney's letter by the June 30 deadline, it's too late now.

Maybe "Pink Limited Information" is good enough for the SEC's September deadline. It's not stated clearly anywhere -- I am having trouble interpreting how the SEC will treat "Pink Limited Information." But if that is all the SEC wants, why did Acropolis bother with quarterly statements for KAST?